Leadership Team

Leadership Team

Great Minds Think Differently

With a collective wealth of industry success, knowledge and drive, our leaders share a passion for reinvigorating healthcare.

Michael Graves

Interim Principal Executive Officer
Mike has served as a member of Eagle’s board of directors since 2013. Mike is Chairman of the board of directors of Nanocopoeia, Inc., and a member of the board of directors of RiboCor, Inc. Mike has a wide variety of pharmaceutical industry experience including his position as CEO and President of

Steve Ratoff

Interim CFO, Principal Financial Officer and Principal Accounting Officer
Steve has served as a member of our board of directors since Eagle’s inception in 2007. From 2010, he has served as President and Chief Executive Officer of NovaDel Pharma, Inc., filling a number of executive positions since joining their board of directors in 2005, and is currently serving as its

Daniel O'Connor

Chief Strategy Officer, Head of Corporate Development
Dan is our Executive Vice President of Biologics and Corporate Development. Dan served as Finance Director from 2011 to May 2013, and has held multiple roles at Eagle during his tenure. Prior to joining Eagle in 2007, Dan held a variety of management positions, such as Senior Analyst at Ethicon (a

Debra Hussain

Head of Commercial for Acute Care/Hospital
Debra joined Eagle as part of Eagle’s 2022 acquisition of Acacia Pharma with 25 years of pharmaceutical industry experience. As Chief Commercial Officer for Acacia, Debra had responsibility for BARHEMSYS® and BYFAVO®. Prior to Acacia, Debra spent 22 years at Eli Lilly and Company in positions of

Reed McClung

Executive Vice President, Oncology Business Development
Reed joined Eagle with more than 30 years of commercial experience and 25 years of pharmaceutical leadership across multiple commercial functions. His oncology/hematology experience spans 16+ years with Novartis, Celgene, and Bristol-Myers Squibb (BMS).